TCI Co., Ltd. (8436)
TWSE
Closed
Oct 2, 2026
Day's Range
104.0052 wk Range
102.50Overview - 8436 - TCI Co., Ltd.
Key Statistics
Valuation
Enterprise Value
9.57B
P/E (Trailing)
‪11.20‬
P/E (Forward)
‪10.14‬
PEG Ratio
‪4.03‬
Price / Sales (TTM)
‪1.66‬
Price / Book
‪1.50‬
EV / EBITDA
‪5.38‬
Profitability
Gross Margin
‪47.42%‬
Profit Margin
‪14.87%‬
Operating Margin
‪18.52%‬
Return on Assets
‪5.79%‬
Return on Equity
‪14.14%‬
Ownership
Shares Outstanding
110.18M
Float
86.19M
Held by Insiders
‪24.78%‬
Held by Institutions
‪10.37%‬
Price stats
Beta
‪0.55‬
50-Day Avg
‪115.37‬
200-Day Avg
‪121.97‬
Dividends
Payout Ratio
‪106.82%‬
Frequency
Annual
Analyst Consensus
4 analysts
Average price target
‪NT$ 135.00‬Market Cap - 8436 - TCI Co., Ltd.
Peers - 8436 - TCI Co., Ltd.
Peer Comparison
Compared with companies in Household & Personal Products listed on TWSE.
Profile Summary - 8436 - TCI Co., Ltd.
About
TCI Co., Ltd. is a biotechnology and health technology company specializing in the research, development, and manufacturing of functional foods, dietary supplements, and skincare products. Founded in 1980 and headquartered in Taipei, TCI operates globally across Asia, North America, and Europe, serving as a contract…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
